KEY TAKEAWAYS
- ACN shares plummeted 18% following fiscal Q3 earnings, finishing the week down nearly 25% in the company’s worst-ever weekly decline
- TD Cowen moved ACN to Hold from Buy, reducing its price target dramatically from $258 to $150
- The company reported a 3% quarterly decline in bookings, with executives attributing delays to deals shifting into fiscal 2027
- Both Truist and Jefferies reduced their targets, with Truist noting approximately $100M revenue headwinds from Middle East geopolitical issues
- Earnings estimates have been lowered by 14 analysts; while no Sell ratings exist, analysts see limited catalysts for near-term improvement
Shares of Accenture (ACN) were hovering around $120–$123 on Monday, continuing a devastating selloff from last week that erased nearly 25% of the company’s market value — marking the worst weekly decline in Accenture’s history.
The downturn kicked off Thursday when ACN plunged 18% to close at $127.98 following the release of fiscal third-quarter earnings. While the company reported revenue of $18.7 billion, slightly missing the $18.78 billion consensus, adjusted earnings per share of $3.80 exceeded the $3.72 estimate. However, the earnings beat proved insufficient to counterbalance concerning forward guidance and a troubling 3% sequential decline in new bookings.
TD Cowen’s Bryan Bergin spearheaded a series of analyst downgrades Monday morning, reversing his stance on ACN from Buy to Hold while slashing his price objective to $150 from $258.
“Our thesis regarding stability preceding a potential turnaround proved incorrect,” Bergin acknowledged. He indicated that maintaining a favorable rating lacked justification “given the deteriorating fundamentals.”
The bookings shortfall emerged as the primary concern. Bergin admitted the 3% contraction “caught us completely off guard” — his models had anticipated at least modest expansion.
Company executives attributed the weakness to multiple large contracts being deferred into fiscal 2027. However, Bergin calculated that even accounting for an estimated $1 billion in postponed deals, managed services bookings would have still contracted — an outcome he believes would have disappointed investors under any circumstances.
Wall Street Slashes Price Objectives Across the Board
Truist Securities reduced its price objective to $150 from $210 while maintaining a Hold rating. The firm identified approximately $100 million in revenue headwinds stemming from Middle East geopolitical tensions, with impacts anticipated to persist through the fourth quarter and possibly longer.
Truist had previously downgraded ACN several weeks ago, highlighting constrained client budgets, AI-related revenue displacement, and geopolitical volatility. Indirect consequences from the Iran situation began materializing during the latter portion of Q3, and the firm anticipates further elongation of client decision-making timelines.
Jefferies analyst Surinder Thind similarly trimmed his price target to $130 from $185 while retaining a Hold rating. Thind had identified weakening demand trends as early as March. He referenced reduced revenue and earnings projections for calendar year 2027 and noted that geopolitical pressures are compounding already subdued discretionary technology spending.
RBC Capital Markets lowered its target to $175 from $253. Guggenheim made a more modest reduction to $185 from $225 but maintained its Buy recommendation.
Current Analyst Sentiment on ACN
Among the 30 firms monitored by FactSet, 17 maintain Buy or Overweight ratings on ACN. The other 13 assign Hold ratings. Notably, zero analysts currently rate the stock as a Sell.
Neverthstanding, InvestingPro data shows that 14 analysts have lowered their earnings projections for the coming period. The stock is now trading close to its 52-week low of $125.60, with technical indicators including the RSI pointing to oversold conditions.
Chief Executive Julie Sweet identified Middle East geopolitical tensions as a contributing factor to the quarter’s underperformance. Meanwhile, the company has maintained its strategic focus on cybersecurity acquisitions and has established collaborative partnerships with OpenAI and Anthropic to develop agentic AI solutions.
ACN shares were changing hands at $120.85 Monday afternoon, representing a decline of approximately 5.6% for the session.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
